Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-09-29

Clinical Trial Update: A Clinical Study of HMPL-506 in Patients With Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical study of HMPL-506 in patients with hematological malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMPL-506 (HMPL-506)

Snippet

Sponsor: Hutchmed | Conditions: Hematological Malignancies | Phase 1 | Status: RECRUITING